ZURA Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
29.3M
+15.0%
25.5M
+38.5%
18.4M
-5.7%
19.5M
+8.1%
18.1M
R&D
20.7M
+40.4%
14.7M
+34.6%
11.0M
-8.3%
11.9M
+37.3%
8.7M
SG&A
8.6M
-19.9%
10.8M
+44.2%
7.5M
-1.5%
7.6M
-19.1%
9.4M
Operating Income
-29321000
-15.0%
-25499000
-38.5%
-18411000
+5.7%
-19519000
-8.1%
-18062000
EBITDA
-29336968
-15.1%
-25483000
-38.5%
-18396000
+5.7%
-19505000
-7.9%
-18070980
Net Income
-26304000
-8.6%
-24223000
-41.0%
-17175000
+4.8%
-18040000
-12.8%
-15993000
EPS (Basic)
$-0.21
+4.5%
$-0.22
+54.2%
$-0.48
-128.6%
$-0.21
-23.5%
$-0.17
EPS (Diluted)
$-0.21
+4.5%
$-0.22
+54.2%
$-0.48
-128.6%
$-0.21
-23.5%
$-0.17
Shares (Diluted)
126.8M
+13.0%
112.2M
+18.4%
94.8M
+0.3%
94.6M
+0.3%
94.3M
Zura Bio (ZURA) โ€” Financials